Who is sponsoring NCT05843045?

NCT05843045 is sponsored by Dayton Children's Hospital.

What drugs are being tested in NCT05843045?

Interventions in NCT05843045: Indoor Air Quality Mitigation.

What condition does NCT05843045 study?

NCT05843045 studies Persistent Asthma.

Is NCT05843045 still recruiting?

NCT05843045 is currently status unknown. Last updated 8 January 2024.

Last reviewed 2024-01-08 · How we verify

NCT05843045: IAQ

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Indoor Air Quality Asthma Study: The Effect of Indoor Air Quality and Mitigation of Same on Persistent Asthma

Status unknown NA Last updated 8 January 2024

What this trial tests

NA trial testing Indoor Air Quality Mitigation in Persistent Asthma in 10 participants. Status unknown.

Timeline

18 August 2023

Primary endpoint
31 August 2025

12 January 2026

Quick facts

Lead sponsor	Dayton Children's Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	triple
Primary purpose	treatment
Enrollment	10
Start date	18 August 2023
Primary completion	31 August 2025
Estimated completion	12 January 2026
Sites	1 location across United States

Drugs / interventions tested

Indoor Air Quality Mitigation

Conditions studied

Persistent Asthma — all drugs for Persistent Asthma →

Sponsor

Dayton Children's Hospital

Who can join

Adults 5 to 15, any sex, with Persistent Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective is to determine whether continuous sensing, control and mitigation of home indoor air quality influences the frequency of asthma related symptoms, as measured by Serum IgE, Spirometry with exhaled Nitric Oxide, missed school and workdays, need for pharmacologic intervention (albuterol, oral steroids), frequency of sick visits to pulmonologist or primary care provider (PCP), urgent care / emergency department visits, and hospitalizations

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Persistent Asthma

Currently open trials in the same condition.

NCT04480242 — Asthma Research in Children and Adolescents · active not recruiting

Other Dayton Children's Hospital trials

Trials by the same sponsor.

NCT04994613 — Use of an Adaptive Sensory Environment in Autism Spectrum Disorder (ASD) Patients in the Perioperative Environment · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05843045 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dayton Children's Hospital
Last refreshed: 8 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05843045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing